Stephen Newlin
Analyst · Northcoast Research
Thanks, Bob, and good morning. Well, the fourth quarter of 2011 brings to a close another strong year for PolyOne and, I mean, highlights the earnings growth potential of the new PolyOne, as we continue to focus on profitable growth in becoming a specialty company that consistently delivers year-over-year earnings growth.
Since Bob has already covered our fourth quarter financial performance, my remarks will focus on our full year accomplishments as we establish a number of records. For the full year, 2011 sales totaled $2.9 billion, a 9% increase from 2010 and a new record for PolyOne. We also delivered record adjusted EPS of $1.02, a 29% increase over prior record, which was set in 2010. These full year results are particularly encouraging as they were generated by record-breaking performances in each of our 3 strategic platforms.
Both the Specialty and Distribution platforms delivered record earnings, and Performance Products & Solutions generated record return on sales. Despite slower economic conditions in the second half of the year, we achieved these record performances as we focused intensely on our 4 pillar strategy.
While we curtailed spending in the second half of 2011, we did not cut back on innovation. In fact, we continue to invest heavily in innovation at PolyOne to support our strategy. Last fall, we conducted our first-ever Innovation Week in which we brought key marketing and technical resources together to share best practices, foster ingenuity and improve our customer-centric innovation skills. We also tapped one of the world's premier thought leaders on innovation, Dr. Clayton Christianson [ph], who helped train and inspire innovators. We're developing solutions to solve our customers' toughest challenges.
I remind you that we measure our success in developing and selling new innovative products through our Vitality Index, which measures the percentage of specialty sales generated from products developed in the last 5 years. During 2011, we achieved a Vitality Index in our Specialty Platform of 38.4%, which reflects top-tier innovation performance for a specialty company.
Recent examples of innovation include our announced collaboration with Siemens Healthcare to develop non-lead radiation shielding components for Siemens' newest line of CT scanners. Using one of PolyOne's Global Specialty Engineered Materials solutions, Trilliant Healthcare Radiation Shielding Compound, Siemens was able to design and produce components with radiation shielding performance equal to lead while being environmentally friendly compared to traditional metal and lead parts. Through this innovation, we are helping healthcare providers incorporate more sustainable materials into their devices while reducing their machining, assembly and their regulatory costs.
We also recognized that the collaboration with additive suppliers is an important part of renovation strategy. Recently, we announced an alliance with SANITIZED AG, a leading producer of antimicrobials, to provide innovative, customizable solutions for specialized healthcare and medical device applications, such as minimally invasive surgical device housings, catheters, hospital furnishings and medical packaging. We're using the antimicrobials and our WithStand antimicrobials solutions, which consists of active ingredients that inhibit the growth of bacteria and viruses on plastic surfaces.
So the next time you're in a doctor's office or hospital, take a quick look around at all of the surfaces and equipment that would benefit from antimicrobial plastics technology. From tubing to bed rails, there are numerous applications where we can help promote better healthcare to our customers and patients around the globe. And in fact, speaking of healthcare, compared to the prior year, PolyOne sales to the healthcare market increased 19% to $269 million in 2011, as a result of our focused efforts to drive growth in this market segment.
In July, we announced an expansion of PolyOne Distribution in Shanghai, making our first entry point for POD in Asia. The Shanghai distribution facility is focused on providing value to healthcare device manufacturers in Asia. Speaking of Distribution, in 2011, POD reached nearly $1 billion in revenues and delivered record operating income of $56 million. That's a 33% increase in operating income over the prior year, and return on sales reached a new high of 5.6% while ROIC reached nearly 50%.
Performance Products & Solutions reported sales of $865 million, up 11% from 2010, yet still 26% below 2006 revenue levels when U.S. housing starts were at 1.8 million units per year. Keep in mind that was 3x the still anemic 600,000 starts we experienced last year. Impressively, and despite these comparatively lower sales than in 2006, our PP&S return on sales reached record levels of 7.2% in 2011, and that's an improvement of 170 basis points over 2006. You may want to talk further with Cynthia Tomasch about this, as she has been leading 2 of our business units within PP&S under Rob Rosenau's leadership. As PP&S continues to drive improvement through innovation and commercial operation excellence, this business will be even better positioned for profitability as its core end markets, like housing, eventually recover, and this provides further upside to these record-setting results.
And while I'm eager to discuss how we'll take advantage of the upside potential across all of our businesses in 2012, I want to focus on Specialty as I look back on 2011 as a pivotal year in our transformation. First, we invested heavily in sales, marketing and technical service resources to support and execute our innovation efforts. While Specialty operating income was a record this year, our results show that we modestly paired short-term results for long-term gains, as we invested approximately $15 million in additional sales, marketing and technical resources.
Second, we sold the last of our commodity-oriented investments, SunBelt. We realized $175 million from that sale before earnouts, and we removed significant volatility from our earnings. And while we were satisfied with the price and multiple at that the time as being mutually fair, we were delighted the total proceeds have been elevated as the business performed well in 2011.
At the time of the sale, we said we intended to use the proceeds to accelerate Specialty Platform growth. We followed through on that commitment and made several exciting investments in 2011 to grow our Specialty Platform. In January, we acquired Uniplen, a specialty engineered materials producer in Brazil. In October, we announced the formation of a color joint venture in Saudi Arabia to expand our footprint in the Middle East.
And of course, we acquired ColorMatrix, a true game changer for PolyOne and the largest acquisition in our company's history. Although the transaction just closed in late December, we're off to a fantastic start together, and the integration is going extremely well. A few weeks ago, I visited the ColorMatrix Global Technology Center in Knowsley, U.K., meeting with employees as part of some integration activities.
I don't think their level of innovation can be overstated. It's something you have to experience and feel as you talk with employees. Some cultures just have it, but most don't. ColorMatrix in their approach to innovation will have positive ripple effects throughout our organization that no one could have predicted. ColorMatrix has a track record of exceptional performance, having organically grown its EBITDA by an annualized growth rate of 16% since 2002. This acquisition further positions PolyOne globally, strengthening our position in Brazil and Asia and creates an entry point into Russia. As a result of incremental investments we expect to make in ColorMatrix, the acquisition will be modestly accretive in 2012 in the range of $0.04 to $0.06 per share and increase to $0.12 to $0.15 in 2013.
ColorMatrix also accelerates the achievement of our Specialty Platform goals, most notably pro forma for the acquisition and the sale of SunBelt, 50% of our earnings now are from Specialty versus just 2% in 2005. This is just one of the 2012 goals we set for ourselves back in 2007, and it's hard to believe it's been 5 years since we first announced those aspirational targets. I am proud to say that we'll either exceed or come very close to meeting each of these extremely aggressive goals, and let me share some proof of that performance.
In return on sales from 2007 to present, consider the progress that we've made towards those lofty goals. Specialty improved from 3.2% to 8%. That's tremendous progress. POD improved from 3% to 5.6%, already surpassing our 2012 expectations, and PP&S improved from 6.1% to 7.2%, tremendous performance considering housing start levels were less than half of what they were in 2007.
We targeted to improve our Vitality Index from 21% in 2007 to the range of 35% to 40% in 2012, and we're already at that target. In 2007, our pretax return on invested capital was 10.8%, and we expect to be very close to the 15% target we set for ourselves by 2012. And as a measure of globalization, we said we wanted at least 40% of our sales to be generated outside the U.S. by 2012, and we will be at or very near this goal.
Of course, now we have to raise the bar higher. And on May 16, we'll host an Investor Day in New York during which we'll communicate our new 2015 goals. In setting these goals, we will hold steadfast to our 4 pillar strategy which remains unchanged. We'll continue to emphasize margin expansion, increase specialty contribution, innovation and international growth, and I hope that is what you've come to expect from PolyOne, higher expectations, continuous improvement consistent with our strategy and our values.
It wasn't an easy year, and we're not in an easy business. And that's what makes me so proud of our performance this past year, and that's what makes my confidence grow in terms of all that we can do and are doing to take this company to greater heights. But before concluding my remarks, I want to share a few of my experiences in early 2012. I spent much of my time so far this year directly with our employee base. And in my travels, I've learned a lot. I started the year with a trip to Asia, meeting and listening to associates there, talking about expectations, areas poised for growth and how we capture it. The next week, I was in the U.K., officially welcoming our ColorMatrix team and supporting their tactical integration sessions.
And just last week, we did something never before done at PolyOne. We brought together our entire team of sellers from around the globe. And joining our sales team were our general managers, who are the leaders that really drive the business performance that Bob and I get the pleasure of reporting to you each quarter. This global meeting was amazing. There were tremendous few days together where we sharpened our sales tools, recognized and planned cross-selling successes, trained our teams on our latest and greatest products and energized our sellers for the coming year.
During this meeting, I had the opportunity to talk with sellers who serve customers throughout 101 countries, and it was one of those rare moments where I actually gave pause to remark on just how far we've come as a company, not just from a globalization standpoint but in our transformation to become a world-class, highly profitable specialty company. And as CEO of this company, I look well beyond the numbers that get rolled up each month and each quarter.
There is tremendous value in talking with our team, especially in our non-headquarter locations. That's where you hear the stories behind the numbers. That's where I learned about one extraordinary seller who last year pruned $2 million worth of commodity business at 2% margins. But she didn't make any excuses, and instead went out and replaced those lost sales with new accounts averaging 30% margins to far more than offset the profitability of what was pruned. Now on a volume basis, her territory volume is considerably lower, but the profitability is substantially higher. This is what we mean by mix improvement, which remains a vital tactic as we execute on our strategy.
Those are the types of stories that are happening every day in our company. They don't always get told on this call, and unfortunately, I don't get to hear them all either. But when I do, it provides the confidence and reassurance that is hopefully conveyed when I speak with you.
PolyOne has enjoyed very good success in recent years. But I submit, we have so much more that we can do and so much more that we will do, thanks to this terrific and engaged team of associates that I have the privilege to lead. And before closing, I'd like to thank our PolyOne associates around the world for their exceptional performance in 2011 and for their continued relentless execution of our 4 pillar strategy.
So that concludes our prepared remarks, and I'd now like to turn the call back to Chantelle, who will open up the lines for your questions.